Amitriptyline metabolism in relation to antidepressive effect

Area of Science:

• Pharmacology
• Clinical Chemistry
• Psychiatry

Background:

• Amitriptyline (AT) is a widely used antidepressant.
• Understanding AT metabolism is crucial for optimizing patient response and minimizing adverse effects.
• Individual variability in drug metabolism can significantly impact treatment outcomes.

Purpose of the Study:

• To investigate the relationship between amitriptyline (AT) metabolism and clinical response in outpatients.
• To quantify serum levels of AT and its primary metabolites.
• To assess the impact of AT therapy on depressive disorder severity.

Main Methods:

• 14 outpatients received a daily dose of 150 mg amitriptyline (AT).
• Riboflavin was used as a compliance marker.
• Serum levels of AT and metabolites (NT, E/Z-10-OH-NT, tot-10-OH-AT, DNT) were measured using HPLC.
• Depressive disorder severity was assessed using the Zung self-rating depression scale.

Main Results:

• Mean steady-state concentrations of AT, NT, and E-10-OH-NT were around 100 µg/l.
• Significant inter-patient variation in metabolic patterns was observed.
• A weak auto-inducible effect of AT or its metabolites was suggested by a 15% decrease in concentrations after 6 weeks.
• Steady-state AT concentrations correlated with NT levels (r=0.64, P<0.05).

Conclusions:

• Amitriptyline (AT) metabolism exhibits substantial inter-individual variability.
• A weak auto-inducible effect of AT may influence its pharmacokinetics.
• The correlation between AT and nortriptyline (NT) steady-state levels suggests a relationship in their metabolic pathways.